Similar articles

• Erythropoietin in Preterm Infants.

  Ehrenreich H, Neubauer AP, Miskowiak K. Ehrenreich H, et al. N Engl J Med. 2020 May 7;382(19):1862. doi: 10.1056/NEJMc2002493. N Engl J Med. 2020. PMID: 32374968 No abstract available.
• Prophylactic Early Erythropoietin for Neuroprotection in Preterm Infants: A Meta-analysis.

  Fischer HS, Reibel NJ, Bührer C, Dame C. Fischer HS, et al. Pediatrics. 2017 May;139(5):e20164317. doi: 10.1542/peds.2016-4317. Epub 2017 Apr 7. Pediatrics. 2017. PMID: 28557760 Review.
• Neuroprotection with erythropoietin in preterm and/or low birth weight infants.

  Zhang J, Wang Q, Xiang H, Xin Y, Chang M, Lu H. Zhang J, et al. J Clin Neurosci. 2014 Aug;21(8):1283-7. doi: 10.1016/j.jocn.2013.10.040. Epub 2014 Feb 6. J Clin Neurosci. 2014. PMID: 24650681 Review.
• Urinary erythropoietin concentrations after early short-term infusion of high-dose recombinant epo for neuroprotection in preterm neonates.

  Dame C, Langer J, Koller BM, Fauchère JC, Bucher HU. Dame C, et al. Neonatology. 2012;102(3):172-7. doi: 10.1159/000339283. Epub 2012 Jul 4. Neonatology. 2012. PMID: 22776958 Clinical Trial.
• Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years.

  Ehrenreich H, Neubauer AP, Miskowiak K. Ehrenreich H, et al. JAMA. 2021 Apr 13;325(14):1470-1471. doi: 10.1001/jama.2021.0833. JAMA. 2021. PMID: 33847720 No abstract available.